Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab. - Wikidata - awgldk - TriplyDB

Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab.

Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab.

http://www.wikidata.org/entity/Q41206130

about

Foveal morphology affects self-perceived visual function and treatment response in neovascular age-related macular degeneration: a cohort study.Rapid and reliable assessment of the contrast sensitivity function on an iPad Visual Function and Its Relationship with Severity of Early, and Activity of Neovascular, Age-Related Macular Degeneration Determinants of patient satisfaction and function related to vision following cataract surgery in eyes with no visually consequential ocular co-morbidity.Performance of a differential contrast sensitivity method to measure intraocular scattering.Evaluation of the precision of contrast sensitivity function assessment on a tablet device.The effect of pre-adapting light intensity on dark adaptation in early age-related macular degeneration.Retinal accumulation of zeaxanthin, lutein, and β-carotene in mice deficient in carotenoid cleavage enzymes.The Role of mf-ERG in the Diagnosis and Treatment of Age-Related Macular Degeneration: Electrophysiological Features of AMD.

P2860

Q35117715-14E0177E-3FF7-49EA-ACFB-847D6BFF43D7 Q36108166-A0BBAD01-4F7E-4756-B760-8CCB90618282 Q38837386-494812DA-DB05-4EB3-B085-AAF6A028771D Q40946094-62A65A26-5CDC-4E0C-AF6C-E11AAD408AAB Q41069087-F33F76B5-3EC0-4878-920A-F2B17C0332EC Q42259687-893144D8-835F-4154-901C-6284DA344ED7 Q45805452-FF0DFE4B-9F38-4387-BF64-3A33B03CB257 Q52782567-515E9670-35D6-4F53-A1A0-FA14BD0B1605 Q53412654-EC2F34A6-5228-4DAC-AD51-9488A3430233

P2860

Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab.

http://www.wikidata.org/entity/Q41206130

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Visual performance in patients ...... with intravitreal ranibizumab.

@en

type

label

Visual performance in patients ...... with intravitreal ranibizumab.

@en

prefLabel

Visual performance in patients ...... with intravitreal ranibizumab.

@en

P1433

Q41206130-D8556B37-5B97-4B13-B8D8-F6E4AD0BF713

P1476

Q41206130-CB1EB07F-D800-48C9-85F3-36A3CF9D1BCD

P2093

Q41206130-06B05D31-D441-4959-9899-F0EDACFDA5BA

Q41206130-19523237-EB89-477C-AC10-2E3A79F81964

Q41206130-58160997-8A43-4580-84BD-A30AD483F52B

Q41206130-EF13B8CC-017B-42AD-AE80-10CC697EB0F3

P2860

Q41206130-10B937A2-A94A-4F00-B815-4C04D8A92C57

Q41206130-1AF5BAD7-192E-4709-A4EA-07974AEE6585

Q41206130-2871DE7D-4E6A-4F65-8A70-41286A6DCECB

Q41206130-3BB10E38-5C42-4B44-B8AD-83B437F1A582

Q41206130-3F27EF1F-0792-4702-BE35-703355BEFB0A

Q41206130-45891434-E781-47FD-A340-0C96A938145F

Q41206130-4B5E1633-1E0F-4ED7-A3D9-49065CFD5FFD

Q41206130-4D443F98-969D-4CB6-A38D-285CC7B1B413

Q41206130-4E918CDC-2764-4943-88C0-F2F856F33DEA

Q41206130-64436451-E1B1-444C-8A66-3F544201A3EE

P304

Q41206130-FFB43F9F-DBAC-43CB-AD0B-5E0A34783ECE

P31

Q41206130-8EFB7B7A-04B2-4CEE-916C-E410C7786ADE

P356

Q41206130-788588F0-BA15-405E-B0DB-DC9C1F3009F4

P478

Q41206130-C188DCE6-06B4-4551-A662-5F8DBECAC701

P50

Q41206130-55EC032B-5FF4-4B9B-AD02-98E4C19FF9EE

Q41206130-5D4D4352-9D05-4047-863F-ECFA7738F047

Q41206130-B5D52D9B-8A8E-4486-B697-11EB02FF0B2C

P577

Q41206130-82E75B39-8A39-44E7-9D23-52AB3DB7EC6C

P5875

Q41206130-BB5318C7-9A18-4A95-AE53-50A5D9E626D0

P698

Q41206130-05F4B2B2-6886-4C75-8374-32E578B98AC2

P932

Q41206130-B39EAF0C-C50D-457C-A018-8E90D1D43B3C

P356

P1433

Journal of Ophthalmology

P1476

Visual performance in patients ...... with intravitreal ranibizumab.

@en

P2093

Jim Stack

http://www.w3.org/2001/XMLSchema#string

Katherine A Meagher

http://www.w3.org/2001/XMLSchema#string

Sarah Sabour-Pickett

http://www.w3.org/2001/XMLSchema#string

Stephen Beatty

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab for neovascular age-related macular degeneration

Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration.

Microperimetry--comparison between the micro perimeter 1 and scanning laser ophthalmoscope--fundus perimetry.

Scanning laser ophthalmoscope microperimetry.

Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration.

Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study.

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Contrast sensitivity.

Outcome of ranibizumab treatment in neovascular age related macula degeneration in eyes with baseline visual acuity better than 6/12.

P304

268438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/268438

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Konrad Pesudovs

P577

2013-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236085239

http://www.w3.org/2001/XMLSchema#string

P698

23533703

http://www.w3.org/2001/XMLSchema#string

P932

3595676

http://www.w3.org/2001/XMLSchema#string